Mesalazine is an aminosalicylate used to treat inflammatory bowel diseases. It works by affecting intestinal cells to change chemical production. Available in various forms including tablets, granules, suppositories, enemas
IBD causes inflammation of digestive tract tissues. Ulcerative colitis affects colon and rectum lining. Crohn's disease involves deeper digestive tract layers. Common symptoms include diarrhea, belly pain, and rectal bleeding
IBD causes inflammation in intestines through immune system attacks. Ulcerative colitis affects colon and rectum, Crohn's affects any part of digestive tract. Genetic factors play role, with 20% having family history. Smoking doubles risk of Crohn's disease
Skyrizi requires prescription and supervision by experienced doctors. Available in pre-filled syringes and pens for psoriasis and arthritis. Treatment starts with 4-week intervals, then every 12 weeks. Patients can self-inject after training if approved
Sulfasalazine is a DMARD used to treat ulcerative colitis, rheumatoid arthritis, and juvenile rheumatoid arthritis. It works by reducing inflammation and limiting joint damage in rheumatoid arthritis. Contains 5-aminosalicylic acid and antibiotic sulfapyridine linked by a bond
Zeposia treats relapsing-remitting multiple sclerosis and ulcerative colitis. Used when standard treatments or biological agents fail. Contains active substance ozanimod, blocking immune system's lymphocyte action